Dennis Mulroy, Chief Financial Officer of ANAPTYSBIO, INC, reported transactions on December 22, 2025. Mulroy acquired 10,000 shares of common stock at $20.16 per share and disposed of 10,000 shares of common stock at $50.00 per share. These transactions were executed under a Rule 10b5-1 trading plan. Additionally, Mul...

This filing details transactions by Mac Ban Ryan Norris, Chief Revenue Officer of Confluent, Inc. On December 22, 2025, Norris sold 1,218 shares of Class A Common Stock at $29.96 per share, resulting in 335,732 shares remaining. On December 23, 2025, an additional 3,053 shares were sold at the same price, leaving 332,6...

David Eugene Maher, President and CEO of Acushnet Holdings Corp. (GOLF), reported a transaction on December 19, 2025. Maher acquired 2234.93 shares of Common Stock at a price of $82.45 per share. This acquisition was part of dividend equivalent rights related to restricted and performance stock units under the company'...

Jennifer H. Mak, Chief Accounting Officer of Axon Enterprise, Inc., reported a sale of 1134 shares of common stock on December 19, 2025. The transaction was executed at a price of $600 per share, totaling $680,400. Following this transaction, Ms. Mak owns 13739.824 shares of common stock. This sale was conducted under ...

This SEC filing (Form 4) details transactions of Horizon Kinetics Holding Corp common stock by several reporting persons, including Maran Partners Fund, LP, Maran Partners GP, LLC, Maran SPV, LP, Maran SPV GP, LLC, Maran Capital Management, LLC, and Daniel J. Roller. On December 23, 2025, Maran Partners Fund, LP acquir...

This SEC filing (Form 4) details transactions of Horizon Kinetics Holding Corp common stock by several reporting persons, including Maran Partners Fund, LP, Maran Partners GP, LLC, Maran SPV, LP, Maran SPV GP, LLC, Maran Capital Management, LLC, and Daniel J. Roller. On December 23, 2025, Maran Partners Fund, LP acquir...

This SEC filing (Form 4) details transactions of Horizon Kinetics Holding Corp common stock by several reporting persons, including Maran Partners Fund, LP, Maran Partners GP, LLC, Maran SPV, LP, Maran SPV GP, LLC, Maran Capital Management, LLC, and Daniel J. Roller. On December 23, 2025, Maran Partners Fund, LP acquir...

This SEC filing (Form 4) details transactions of Horizon Kinetics Holding Corp common stock by several reporting persons, including Maran Partners Fund, LP, Maran Partners GP, LLC, Maran SPV, LP, Maran SPV GP, LLC, Maran Capital Management, LLC, and Daniel J. Roller. On December 23, 2025, Maran Partners Fund, LP acquir...

This SEC filing (Form 4) details transactions of Horizon Kinetics Holding Corp common stock by several reporting persons, including Maran Partners Fund, LP, Maran Partners GP, LLC, Maran SPV, LP, Maran SPV GP, LLC, Maran Capital Management, LLC, and Daniel J. Roller. On December 23, 2025, Maran Partners Fund, LP acquir...

This filing details stock transactions by John M. Markovich, Chief Financial Officer of D-Wave Quantum Inc. On December 22, 2025, Markovich exercised stock options to acquire 100,000 shares at $0.92 per share and subsequently sold 100,000 shares of Common Stock at a weighted average price of $30.0262 per share. These t...

Mark Maughan, Chief Operating Officer of DOMO, INC., reported a transaction on December 20, 2025. He disposed of 4,708 shares of Class B Common Stock, with a per-share price of $9.19. This transaction was related to tax withholding upon vesting of restricted stock units. Following this transaction, Maughan holds 236,91...

Maxwell Raina, a director at Camden National Corp, acquired 312 shares of common stock on December 19, 2025. These shares were obtained under the company's 2022 Equity and Incentive Plan, as an alternative to director fees. Following this transaction, Mr. Raina now holds 2471.637 shares. The filing also notes that 23.2...

This filing details significant stock transactions by McBee Brannin, Chief Development Officer of CoreWeave, Inc., on December 22, 2025. Brannin acquired 102,835 shares of Class A Common Stock directly and an additional 132,835 shares through various trusts and entities, including the Brannin J. McBee 2022 Irrevocable ...

This filing details a transaction by Patrick McCall, the Chief Financial Officer of IN8BIO, INC. On December 22, 2025, McCall acquired 7,247 shares of common stock at a price of $1.38 per share. Following this transaction, McCall now owns 9,482 shares. It is important to note that the reported share quantities have bee...

This Form 4 filing reports that William M. Shaver, Chief Operating Officer and Director of McEwen Inc. (MUX), received 20,407 shares of common stock through the vesting of restricted stock units on December 20, 2025. The shares were acquired at $0.00 per share as part of equity compensation awards. The transactions inv...

This filing details stock transactions by Stephan Michael Spears, VP Corporate Development at McEwen Inc. On December 20, 2025, Spears disposed of 1,200 Restricted Stock Units (RSUs) and 500 RSUs, both originally granted in 2025. These RSUs were settled in cash, with their vesting schedules having been accelerated. Eac...

This Form 4 filing details a transaction by William J. McNally, Chief Accounting Officer of En সুস্পষ্টvision Communications Corp. On December 20, 2025, McNally disposed of 49,875 shares of Class A common stock. This disposal was to satisfy tax withholding obligations related to the vesting of restricted stock units gr...

Susanne Meline, a director at MDB Capital Holdings, LLC, reported a transaction on August 14, 2025. She acquired 10,000 shares of Common Stock at a price of $3.4 per share, increasing her post-transaction holdings to 30,000 shares. Additionally, she acquired 10,000 Restricted Stock Units (RSUs) with an exercise price o...

On December 22, 2025, Jayme Mendal, CEO and President of EverQuote, Inc., sold 14,360 shares of Class A Common Stock. The sale was executed as part of a Rule 10b5-1 trading plan adopted on December 17, 2024. The shares were sold at a weighted average price of $27.25 per share, with individual transactions ranging from ...

Jennifer Newstead, Chief Legal Officer at Meta Platforms, Inc. (META), reported a sale of 519 shares of Class A Common Stock on December 23, 2025. The transaction, executed as part of a Rule 10b5-1 trading plan, occurred at a price of $659.38 per share. Following this transaction, Newstead directly owns 29,177 shares o...

Javier Olivan, Chief Operating Officer of Meta Platforms, Inc., reported the sale of 517 shares of Class A Common Stock on December 22, 2025, under a Rule 10b5-1 trading plan. The transaction occurred at a price of $661.11 per share, resulting in a post-transaction share ownership of 12,717 shares. The filing also deta...

Suzanne N Mikes, EVP and Chief Credit Officer of CONSUMERS BANCORP INC /OH/, acquired 100 shares of Common Stock on December 23, 2025, at a price of $24.10 per share. This transaction was made under a dividend reinvestment plan. Following this acquisition, Mikes holds 9182.826 shares of the company's stock. The filing ...

William H. Milmoe, a 10% owner of Celsius Holdings, Inc., reported the settlement of three tranches of a prepaid variable forward sale contract on December 19, 22, and 23, 2025. These settlements involved the physical delivery of Celsius Holdings common stock. Specifically, 115,374 shares were delivered on December 19,...

This filing details a Form 4 submission by G. Jan Van Heek, a director at Minerva Neurosciences, Inc. (NERV). On December 22, 2025, Van Heek was granted a stock option to purchase 50,000 shares of Common Stock at a price of $3.98 per share. The option vests in four equal quarterly installments starting three months aft...

This filing details a stock option grant to Geoff Race, President of Minerva Neurosciences, Inc. On December 22, 2025, Race was granted 1,500,000 employee stock options with a purchase price of $3.98 per share, vesting commencing December 22, 2026. The options are exercisable until December 21, 2035. The filing also in...